Peripheral blood mononuclear cells (PBMCs) were obtained from healthy volunteers with informed consent using a Baylor College of Medicine institutional review board-approved protocol (H-45017) and were used to generate phytohemagglutinin (PHA) blasts and multiVSTs. PHA blasts were generated as previously reported (9 (link)) and cultured in T cell medium [45% RPMI 1640 (HyClone Laboratories, Logan, Utah), 45% Click’s medium (Irvine Scientific, Santa Ana, California), 2 mM GlutaMAX TM-I (Life Technologies, Grand Island, New York), and 5% human AB serum (Valley Biomedical, Winchester, Virginia)] supplemented with 100U/ml interleukin 2 [IL2; Proleukin® (aldesleukin), TCH, Houston, TX], which was replenished every 2 days.
Free full text: Click here